SM
DMTK

Senvest Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Senvest Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-251,000
Closed -$3.97M – 98
2021
Q4 		$3.97M Buy
+251,000
New +$6.03M 0.11% 53

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Senvest Management's DMTK Position: Q1 2022 in Review

Senvest Management sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2022, closing a stake of 251,000 shares — an estimated $3.97M sold.

Senvest Management first reported a position in DMTK in Q4 2021 and held it in 1 quarter. The position peaked at $3.97M in Q4 2021. 151 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

  • Senvest Management reported no remaining DermTech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Senvest Management sold 251,000 DermTech, Inc. Common Stock shares in Q1 2022, an estimated $3.97M.
  • Senvest Management first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Senvest Management's DermTech, Inc. Common Stock position peaked at $3.97M in Q4 2021.
  • 151 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Senvest Management's 13F filing for Q1 2022, filed 13 May 2022.